INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Public company

SERSerina Therapeutics, Inc.

CIK 0001708599

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells1 / 0
Max Insider Score47
Connections4with evidence

SER · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
MP
Marshall Richard PeterDirector
SERSerina Therapeutics, Inc.
Grant or award
A—
15.3K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Tenjarla SriniSVP, CMC & Formulation · Feb 17, 2026
  • ← Insider ofevidence
    Marshall Richard PeterDirector · Nov 10, 2025
  • ← Insider ofevidence
    Brannan Stephen K.Director · Nov 10, 2025
15
TS
Tenjarla SriniSVP, CMC & Formulation
SERSerina Therapeutics, Inc.
Grant or award
A
—
85.6K sh
May 21, 2026
May 26, 2026
traded May 21, 2026
+5d
SEC FORM 4

Evidence

47
MP
Marshall Richard PeterDirector
SERSerina Therapeutics, Inc.
Open-market purchase
BUY$20K
12.2K sh
May 19, 2026May 22, 2026
traded May 19, 2026
+3dSEC FORM 4

Evidence

19
TS
Tenjarla SriniSVP, CMC & Formulation
SERSerina Therapeutics, Inc.
Grant or award
A—
69.0K sh
Feb 3, 2026Feb 17, 2026
traded Feb 3, 2026
+14dSEC FORM 4

Evidence

9
MP
Marshall Richard PeterDirector
SERSerina Therapeutics, Inc.
Grant or award
A—
10.0K sh
Nov 7, 2025Nov 10, 2025
traded Nov 7, 2025
+3dSEC FORM 4

Evidence

9
BK
Brannan Stephen K.Director
SERSerina Therapeutics, Inc.
Grant or award
A—
10.0K sh
Nov 7, 2025Nov 10, 2025
traded Nov 7, 2025
+3dSEC FORM 4

Evidence